Andere talen Apyx Medical Corporation

Aandelen

APYX

US03837C1062

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,5 ^USD	+13,64%		+7,91%	-42,75%

05/04	Archon Capital Management gaat in gesprek met Apyx Medical Corporation	CI
01/04	Stavros G. Vizirgianakis in gesprek met Apyx Medical Corporation	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT	12/04
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit	11/04
Archon Capital Management Engages with Apyx Medical Corporation	05/04
Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	01/04
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK	22/03
Apyx: Q4 Earnings Snapshot	21/03
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook	21/03
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	21/03
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
North American Morning Briefing : Investors -2-	21/03
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024	04/03
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING	22/02
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting	21/02
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY	23/01
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	22/01
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	22/01
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue	08/01
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results	08/01
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	08/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Apyx Medical Corporation

Aandelen

APYX

US03837C1062

Andere talen

Filters